Skip to main content
. 2015 Jan 1;75(3):475–483. doi: 10.1007/s00280-014-2664-9

Table 2.

Toxicities in phase 1 (n = 15)

Level 1 (n = 3) Level 2 (n = 6) Level 3 (n = 6)
Grade 1 2 3 4 1 2 3 4 1 2 3 4
Anemia 2 1 0 0 2 1 0 0 1 1 0 0
Blood bilirubin increased 0 0 0 0 1 0 0 0 1 0 0 0
Creatinine increased 0 0 0 0 2 0 0 0 0 0 0 0
Hyperglycemia 1 1 0 0 2 0 1 0 1 0 0 0
Neutrophil count decreased 0 0 0 0 0 0 0 0 0 1 0 0
Platelet count decreased 0 0 0 0 1 0 0 0 1 0 0 0
White blood cell count decreased 0 0 0 0 0 0 0 0 3 0 0 0
Anorexia 1 0 0 0 2 0 0 0 2 1 1 0
Diarrhea 0 0 0 0 4 0 0 0 5 1 0 0
Dry mouth 0 0 0 0 1 0 0 0 1 0 0 0
Dry skin 0 0 0 0 2 0 0 0 2 0 0 0
Fatigue 1 0 0 0 3 0 0 0 1 0 0 0
Oral mucositis 0 0 0 0 2 0 0 0 4 1 0 0
Nausea 1 0 0 0 1 0 0 0 3 0 1 0
Papulopustular rash 0 0 0 0 0 0 0 0 1 0 0 0
Pruritus 0 0 0 0 3 0 0 0 4 0 0 0
Acneiform rash 0 0 0 0 1 0 0 0 1 0 0 0
Maculopapular rash 0 0 0 0 3 0 0 0 3 0 0 0
Nasal mucositis 0 0 0 0 0 0 0 0 1 0 0 0
Vomiting 0 0 0 0 1 0 0 0 2 0 0 0